NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 317 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $216,580 | -38.1% | 2,000 | -47.7% | 0.06% | -41.4% |
| Q1 2024 | $349,835 | +46.0% | 3,825 | 0.0% | 0.10% | +30.3% |
| Q4 2023 | $239,598 | +8.3% | 3,825 | -4.0% | 0.08% | -6.2% |
| Q1 2023 | $221,247 | -2.5% | 3,985 | -23.1% | 0.08% | -1.2% |
| Q3 2022 | $227,000 | -80.3% | 5,185 | -84.1% | 0.08% | -78.1% |
| Q2 2022 | $1,155,000 | -9.6% | 32,600 | +3.9% | 0.38% | +14.7% |
| Q1 2022 | $1,277,000 | -63.1% | 31,390 | -15.4% | 0.33% | -58.1% |
| Q4 2021 | $3,464,000 | -39.8% | 37,095 | -28.2% | 0.78% | -40.8% |
| Q3 2021 | $5,755,000 | +27.3% | 51,640 | +29.7% | 1.32% | +29.5% |
| Q2 2021 | $4,520,000 | – | 39,815 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |